Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (16)
  1. 14. Dauby, N. (2017). Maternal immunization. The New England journal of medicine, 376(25), 2496-2497. doi:10.1056/NEJMc1705482
  2. 15. Dauby, N. (2016). To the editor. The New England journal of medicine, 375(2), 193. doi:10.1056/NEJMc1604016
  3. 16. Dauby, N. (2015). B cell responses in pregnancy and vaccine efficacy. Human reproduction update, 21(3), 407-408. doi:10.1093/humupd/dmv009
    4.   Participations à des congrès et colloques internationaux (19)
  4. 1. Motet, C., Libois, A., Martin, C., & Dauby, N. (2023). Awareness and acceptability of herpes zoster vaccination in people living with HIV [poster]. HIV medicine,(24-5).
  5. 2. Verdebout, I., Sánchez Sánchez, G., Tafesse, Y., Dauby, N., Cogan, A., donner, C., Papadopoulou, M., & Vermijlen, D. (2023). A common genetic variation regulates the development of Vγ9Vδ2 versus nonVγ9Vδ2 γδ T cells. Poster présenté à la conférence Joint Belgian-Dutch Immunology Meeting 2023 (20-21/11/2023: Flanders Meeting & Convention Center Antwerp, Antwerp, Belgium).
  6. 3. Verdebout, I., Sánchez Sánchez, G., Tafesse, Y., Dauby, N., Cogan, A., donner, C., Papadopoulou, M., & Vermijlen, D. (2023). A common genetic variation regulates the development of Vγ9Vδ2 versus nonVγ9Vδ2 γδ T cells. Poster présenté à la conférence 10th Internationnal gd T cell Conference (20-23/06/2023: Chapalimaud Foundation, Lisbon, Portugal).
  7. 4. Verdebout, I., Sánchez Sánchez, G., Tafesse, Y., Dauby, N., Cogan, A., donner, C., Papadopoulou, M., & Vermijlen, D. (2023). A common genetic variation regulates the development of Vγ9Vδ2 versus nonVγ9Vδ2 γδ T cells. Poster présenté à la conférence ATCR2023 meeting (03 and 04.05.2023: University of Antwerp).
  8. 5. Verdebout, I., Sánchez Sánchez, G., Tafesse, Y., Dauby, N., Cogan, A., donner, C., Papadopoulou, M., & Vermijlen, D. (2023). A common genetic variation regulates the development of Vγ9Vδ2 versus nonVγ9Vδ2 γδ T cells. Poster présenté à la conférence ATCR2023 meeting (3-4 May 2023: University of Antwerp).
  9. 6. Martin, C., Domingo, C., Bottieau, E., Buonfrate, D., De Wit, S., Van Laethem, Y., & Dauby, N. (2022). Immunogenicity and duration of protection after yellow fever vaccine in people living with HIV: A systematic review. Poster présenté à la conférence 8th Northern European Conference on Travel Medicine (NECTM8) (June 8-10, 2022: Rotterdam - The Netherlands).
  10. 7. Martin, C., Florence, E., Domingo, C., Delforge, M., De Wit, S., & Dauby, N. (2022). Seroconversion and antibody persistence after yellow fever vaccination in people living with HIV: impact of baseline HIV viral load and yellow fever seropositivity. Paper session presented at 8th Northern European Conference on Travel Medicine (NECTM8) (June 8-10, 2022: Rotterdam - The Netherlands).
  11. 8. Maertens, K., De Brabandere, L., De Weerdt, L. L., Tommelein, E., Vercoutere, A., Dauby, N., Ariën, K., Desombere, I., Marchant, A., & Leuridan, E. (2021). Immune responses to different COVID-19 vaccine platforms in pregnancy. Poster présenté à la conférence Keystone Symposium. Maternal-Fetal Newborn Immunity (28-29/10/2021: Virtual).
  12. 9. Dauby, N., Gerard, M., Bourgeois, M., Delaere, B., Magerman, K., Jouck, D., Reynders, M., Petit, E., Lacor, P., Hoeland, X., Lissoir, B., Thomas, I., Barbezange, C., & Bossuyt, N. (2019). RSV infection in hospitalized adults with severe acute respiratory infection during four influenza seasons in Belgium: prevalence, subtype distribution, risk factors & outcome. Abstract session presented at ECCMID(29: 24/04/2019: Amsterdam)
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Suivant >>